ArticleRadiology case reports2026
Spinal myeloid sarcoma as a first sign of acute myeloid leukaemia: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myeloid sarcomas, also called granulocytic sarcomas or chloromas, are rare extramedullary tumours of immature myeloid cells, most often associated with acute myeloid leukaemia (AML). Spinal involvement is particularly uncommon and typically manifests with neurological symptoms due to nerve compression. We report a 58-year-old male with right lumbar pain radiating to the foot and intermittent paraesthesia. MRI revealed an extramedullary spinal mass compressing the right L5 nerve root and infiltrating the L5 vertebral body, with confirming the diagnosis of AML. PET-CT and follow-up MRI demonstrated extensive paraspinal and spinal canal infiltration. The patient initially developed rapid neurological decline with impaired gait and reflexes despite treatment, though subsequent combined systemic and intrathecal chemotherapy achieved partial regression in size and complete metabolic activity. The patient is currently planned for radiotherapy and stem cell transplantation. Spinal myeloid sarcomas are rare but clinically significant in patients with myeloid malignancies presenting with neurological deficits. MRI is the preferred imaging modality, but histopathology remains essential for diagnosis. Management generally requires systemic chemotherapy, with radiotherapy as adjunctive therapy. Prognosis remains guarded, particularly in cases complicated by spinal cord compression. Myeloid sarcoma should be considered in the differential diagnosis of spinal masses in AML. Early recognition and aggressive treatment resulted in a favourable outcome for our patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.